Health
TGA investigates three new blood clot cases likely linked to AstraZeneca jab in Australia – SBS News
The AstraZeneca vaccine has been recommended for people over 50, with Pfizer the preferred jab for Australians under 50 due to cases of blood clots.
Federal health authorities are investigating three more cases of blood clots that are likely linked to the AstraZeneca vaccine.
The Therapeutic Goods Administration said it had reviewed suspected thrombosis with thrombocytopenia syndrome (TTS) in an 80-year-old Victorian man, a 49-year-old Queensland man and a 35-year-old NSW woman.
The Vaccine Safety Investigation Group
-
Business13 hours agoRanking the best “Magnificent Seven” stocks to buy for 2026. Here’s my No. 5 pick.
-
General15 hours agoSex work influencers call out lack of transparency as young girls targeted by viral social media content
-
Noosa News12 hours agoGaming policy on council’s agenda
-
Business15 hours agoWhere to invest $10,000 in ASX ETFs this December